Inqo Investments Ltd - Unaudited results for period ended 31 August 2023
Announcement provided by
Inqo Investments Limited · INQO29/11/2023 07:00
Inqo Investments Limited
Unaudited Group Results for the period ended 31 August 2023
CHAIRMAN AND CHIEF EXECUTIVE'S STATEMENT
Inqo Investments Limited ("Inqo" or "the Group") is a South African based social impact company that invests in businesses that tackle poverty and environmental challenges in Sub-Saharan Africa.
COMMENTARY
The Group remains in a strong financial position with total assets of R285,367,338 and minimal debt.
The funds that the Company received from Belmont University in the latter part of the 2022/3 financial year and the new shareholder funds received in the early part of the current 2023/4 financial year will be used to develop Inqo's Conservation and Rural Enterprise (CARE) project that will invest in businesses that tackle social and environmental issues in and around the Budongo Forest in
Like businesses around the world, the Group has been heavily impacted by the Covid-19 pandemic with reduced earnings and implementation of cost saving measures. The severity of the impact and corresponding speed of recovery has varied across investee companies. Despite the challenges being faced, the directors of the Company have assessed the Company and its subsidiaries and agree that the operating units will continue as a going concern.
The results for the period under review showed revenue of R7,366,899 (August 2022: R3,389,258) with a profit after tax of R57,444,000 (August 2022: loss of R4,327,761). The primary reason for the profit before tax position is due to the grant income recognised between 1 September 2022 and 31 August 2023 for the cost of planting Spekboom cuttings on the property through the Reforest Action carbon credit contract.
The profit for the period is reported after accounting for the following income and cost items:
|
August 2023 |
August 2022 |
Income earned: Included in other income is donation received for the cost of planting Spekboom cuttings on the property in terms of the Reforest Action carbon credit contract. The value of the donations received between 1 September 2022 and 28 February 2023 amounted to R9,090,000 Operating costs incurred: Depreciation & amortisation Listing expenses Directors' fees and salaries Professional fees Impairment & fair value adjustments Provision for bad & doubtful debts |
61 513 070
1 605 019 372 904 486 168 306 600 24 822 160 321 |
-
1 730 282 428 462 490 403 315 678 57 142 137 275 |
In August 2023, the directors of Inqo reviewed the valuation placed on all income earning assets to ensure that they reflect their fair value. Following the reviews, the directors are of the view that Group assets as stated in the Balance Sheet are reflected at fair value. In the process of carrying out this review it was decided that the following value adjustments should be processed.
· The Kuzuko Lodge operation, whilst steadily improving, has not yet returned to pre Covid-19 occupancies and still operates at a loss. Inqo has provided for impairment of Kuzuko receivables to the value of R2,750,937 against the total amount due of R4,076,944.
· There have been major operational changes at Kuzuko Lodge in that the group has decided, effective 31 October 2023, to part ways with the management company, Legacy Hospitality Management Services (Pty) Ltd. This parting of ways has been entered into in a very fair, balanced and equitable manner.
· Mr J. Tan was appointed CEO of Kuzuko Lodge in July 2023 and he is now working with his fellow directors to put in place a new and effective management structure. The building of the new management unit is operating smoothly and on track to be fully operational before the summer season begins in November 2023.
· The game on the property has not seen any major change in numbers on the land or in value and therefore there are no material changes in the game valuation at 31 August 2023.
· The only non-South African company where Inqo held investments on 28th February 2023 that required assessment from a fair value adjustment perspective was Four One Financial Services Limited. The company has struggled financially but managed to remain operational, however in the process has defaulted on loan and interest repayments. The consequences of this are that the full loans made by Inqo with a value of R753,537 have been impaired and a provision for doubtful debts have been raised against interest owing of R1,217,613.
The land and buildings are in terms of Inqo's accounting policies to be revalued every two years by an independent valuer. The valuation was done in March 2023 as required. The fact that the Eastern Cape has recovered from the drought experienced in previous years and that there have been sales of farmland in neighbouring areas resulted in the land and buildings having increased in value by R19,099,881.
INVESTEE COMPANIES
· Kuzuko Lodge (Pty) Ltd (
· Inqo Africa (Pty) Ltd (
· Spekboom Trading (Pty) Ltd (
· Four One Financial Services Limited (
· Kentegra (
· South Lake Medical Centre - SLMC (
· Sanergy Incorporated (
STOCK EXCHANGE LISTING
The company is listed on the Aquis Exchange PLC (AIM:AQX) in
SUMMARY OF SOCIAL & ENVIRONMENTAL METRICS SINCE PROJECT COMMENCEMENT
· 35,617 acres (14,414 hectares) of former farmland restored as a game reserve in a region of endemic poverty in the poorest province in
· Increased VAT and income tax paid by Kuzuko year on year.
· All staff living at Kuzuko in standard housing with flush toilets, power, water and solar panels.
· Conservation of 3 endangered species.
· Kuzuko has re-wilded 14 adult cheetah and produced 10 cubs with diverse genetics to bolster the meta-population in southern
· Reforestation of 500 acres (200 hectares) of degraded land with Spekboom plants providing work for 100 part-time staff and sequestering carbon in prior financial periods.
· 37 acres (15 hectares) of land between the reception area of the Lodge and the Lodge area has been replanted with various forms of vegetation to recover heavily degraded land on the property. As part of this erosion recovery process 100,000 Spekboom cuttings have been planted.
· 2,100+ voluntary low-income savers in micro-pension and loan schemes.
· 63,423 patient visits in the first 9 months of 2023 including 386 HIV patients receiving care and counselling, 5,599 people receiving health education including through community outreach and 149 surgeries in the new surgical unit which is the only surgical facility at the southern end of Lake Naivasha,
· 4,000 toilets serving 125,000 people daily in
· The reforestation contract planting program, in terms of the contract signed on 5 August 2022, is in progress. 5,701 acres (2,307 hectares) of land have been planted with Spekboom cuttings by 31 August 2023. The project currently employs between 200 and 250 local previously unemployed individuals in the planting process.
STAFF
The directors would like to take this opportunity to thank all the operating staff in the Group for their contribution and commitment to the Group's objectives during this challenging time.
FINANCIAL INFORMATION
The financial information set out in this announcement does not constitute statutory financial statements. This financial information has been extracted from Inqo's unaudited group financial statements for the period ended 31 August 2023.
DIVIDEND
The company has not declared a dividend the period ended 31 August 2023.
K.S Tan C.J Bertie
Chairman Chief Financial Officer
Issued on: 29 November 2023
Enquiries
Inqo Investments Limited |
Tel: +44 7768 613346 |
Dr Kim Tan, Chairman |
Email: kimtan2@springhilluk.com |
|
|
Hobart Capital Markets LLP |
|
AQSE Corporate Adviser and Broker |
Tel: +44 (0)20 7070 5665 |
Dr Wang Chong |
Email: wang.chong@hobartcapital.com |
Condensed consolidated statement of profit or loss and other comprehensive income
for the six months ended 31 August 2023
|
|
|
|
Six Months ended 31 August 2023 |
|
Six Months ended 31 August 2022 |
|
|
|
|
|
R |
|
R |
|
Revenue |
|
|
|
7 366 899 |
|
3 389 258 |
|
Cost of Sales |
|
|
|
(1 049 896) |
|
(481 850) |
|
Gross profit |
|
|
|
6 317 003 |
|
2 907 408 |
|
Other income |
|
|
61 793 066 |
|
761 454 |
|
|
Personnel expenses |
|
|
(2 854 379) |
|
(1 962 577) |
|
|
Directors' emoluments |
|
|
(486 169) |
|
(490 403) |
|
|
Depreciation & amortisation |
|
|
(1 605 019) |
|
(1 730 282) |
|
|
Listing expenses |
|
|
(372 904) |
|
(428 462) |
|
|
Professional fees |
|
|
(306 600) |
|
(315 678) |
|
|
Provision for doubtful debts |
|
|
(160 321) |
|
(137 275) |
|
|
Impairment and fair value adjustment |
|
|
(24 822) |
|
(57 142) |
|
|
Selling and administrative expenses |
|
|
(6 511 330) |
|
(3 826 319) |
|
|
Operating profit/(loss) |
|
|
|
55 788 525 |
|
(5 279 276) |
|
Inventory write-up (down) |
|
|
|
8 000 |
|
- |
|
Fair value adjustment |
|
|
|
296 460 |
|
- |
|
Net financing income |
|
|
|
1 132 991 |
|
102 949 |
|
Finance income |
|
|
|
1 218 522 |
|
184 255 |
|
Finance costs |
|
|
|
(85 531) |
|
(81 306) |
|
|
|
|
|
|
|
|
|
Profit/(Loss) before taxation |
|
|
|
57 225 976 |
|
(5 176 327) |
|
Taxation credit |
|
|
|
218 024 |
|
848 566 |
|
Loss for the period |
|
|
|
57 444 000 |
|
(4 327 761) |
|
Loss attributable to: |
|
|
|
|
|
|
|
Equity holders |
|
|
|
57 565 554 |
|
(4 216 047) |
|
Non-controlling interest |
|
|
|
(121 554) |
|
(111 714) |
|
|
|
|
|
57 444 000 |
|
(4 327 761) |
|
Other comprehensive income: |
|
|
|
|
|
|
|
Other comprehensive income |
|
|
|
- |
|
- |
|
Total comprehensive income for the period |
|
|
|
57 444 000 |
|
(4 327 761) |
|
Condensed consolidated statement of financial position
as at 31 August 2023
|
|
|
Reviewed 31 August 2023 |
|
Audited 28 February 2023 |
|
|
|
|
R |
|
R |
|
Assets |
|
|
|
|
|
|
Non-current assets |
|
|
223 643 437 |
|
163 310 393 |
|
Property, plant and equipment |
|
|
214 355 118 |
|
154 054 726 |
|
Intangible assets |
|
|
1 340 |
|
1 840 |
|
Right of use asset |
|
|
152 975 |
|
236 171 |
|
Other investments |
|
|
9 134 004 |
|
9 017 656 |
|
|
|
|
|
|
|
|
Current assets |
|
|
61 723 901 |
|
46 946 317 |
|
Inventories |
|
|
5 055 693 |
|
4 862 236 |
|
Trade and other receivables |
|
|
3 858 133 |
|
3 124 989 |
|
Biological assets |
|
|
3 085 440 |
|
2 788 980 |
|
Cash and cash equivalents |
|
|
49 724 635 |
|
36 170 112 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
61 723 901 |
|
46 946 317 |
|
|
|
|
|
|
|
|
Total assets
|
|
|
285 367 338 |
|
210 256 710 |
|
Equity and liabilities |
|
|
|
|
|
|
Capital and reserves |
|
|
|
|
|
|
Ordinary share capital |
|
|
72 584 925 |
|
72 584 925 |
|
Share premium |
|
|
87 585 270 |
|
87 585 270 |
|
Revaluation reserve |
|
|
86 693 347 |
|
86 693 347 |
|
Accumulated loss |
|
|
(32 536 242) |
|
(90 101 796) |
|
Equity attributable to equity holders of: Inqo Investments Limited Non-controlling interest |
|
|
214 327 290
38 665 |
|
156 761 746
160 218 |
|
Total equity |
|
|
214 365 965 |
|
156 921 964 |
|
|
|
|
|
|
|
|
Non-current liabilities |
|
|
9 196 420 |
|
9 403 433 |
|
Loans from related parties |
|
|
3 803 662 |
|
4 511 589 |
|
Deferred taxation |
|
|
795 796 |
|
4 815 985 |
|
Lease liability |
|
|
4 596 961 |
|
76 859 |
|
|
|
|
|
|
|
|
Current liabilities |
|
|
61 804 953 |
|
43 931 313 |
|
Bank overdraft |
|
|
532 409 |
|
146 855 |
|
Trade and other payables |
|
|
8 064 296 |
|
8 503 452 |
|
Unutilised grant funding |
|
|
52 994 005 |
|
35 066 926 |
|
Lease liability |
|
|
217 243 |
|
214 080 |
|
Total liabilities |
|
|
71 001 373 |
|
53 334 746 |
|
Total equity and liabilities |
|
|
285 367 338 |
|
210 256 710 |
|
Condensed consolidated statement of cash flows
for the six months ended 31 August 2023
|
|
Six months ended 31 August 2023 |
|
Six months ended 31 August 2022 |
|
||||||
|
|
R |
|
R |
|
||||||
|
Cash utilised by operations |
|
(4 901 289) |
|
(2 686 488) |
|
|||||
|
Interest received |
|
1 218 522 |
|
184 255 |
|
|||||
|
Interest paid |
|
(85 531) |
|
(81 306) |
|
|||||
|
Net cash flow from operating activities |
|
(3 768 298) |
|
(2 683 539) |
|
|||||
|
|
|
|
|
|
|
|||||
|
Cash flows from investing activities |
|
|
|
|
||||||
|
Loan (extended to)/ repaid by other investments |
|
(141 170) |
|
- |
|
|||||
|
Acquisition of property, plant and equipment |
|
(300 055) |
|
(57 539) |
|
|||||
|
Proceeds on disposal of biological assets |
|
248 100 |
|
- |
|
|||||
|
Grant funding received |
|
17 066 111 |
|
- |
|
|||||
|
Proceeds on disposal of property, plant and equipment |
|
58 696 |
|
- |
|
|||||
|
Net cash flow from investing activities |
|
16 931 682 |
|
(57 539) |
|
|||||
|
|
|
|
|
|
|
|||||
|
Cash flows from financing activities |
|
|
|
|
||||||
|
Loans received from related parties |
62 000 |
|
2 804 544 |
|
||||||
|
Other loans received external |
25 869 |
|
- |
|
||||||
|
Repayment of finance lease |
(82 284) |
|
(119 287) |
|
||||||
|
Net cash flow from financing activities |
|
6 585 |
|
2 685 257 |
|
|||||
|
|
|
|
|
|
|
|||||
|
Net movement in cash and cash equivalents |
13 169 969 |
|
(55 821) |
|
||||||
|
Cash and cash equivalents at beginning of year |
36 023 257 |
|
(16 520) |
|
||||||
|
Cash and cash equivalents at end of year |
|
49 192 226 |
|
(72 341) |
|
|||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.